Supernus Pharmaceuticals
SUPN
SUPN
93 hedge funds and large institutions have $309M invested in Supernus Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
24% less capital invested
Capital invested by funds: $405M → $309M (-$95.9M)
Holders
93
Holding in Top 10
6
Calls
$2.13M
Puts
$1.1M
Top Buyers
| 1 | +$3.39M | |
| 2 | +$2.61M | |
| 3 | +$2.37M | |
| 4 |
JG
Jefferies Group
New York
|
+$2.24M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$1.98M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$9.31M | |
| 3 | -$6.26M | |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$5.05M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.28M |